Sweden is investing €8.5 million in a new molecular medicine laboratory at Umeå University, focusing on infectious diseases.
Image courtesy Department of Molecular Biology,
Umeå
The decision to invest in Umea followed a review of the applications by an international panel. The aim of this initiative is to strengthen Swedish research in the field and increase career opportunities for young scientists. Umeå University itself will put Euros 10 million into the lab over the next three years.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.